謝仲明 / Chung-Ming Hsieh
Professional Experience
- Vice President, Protein Therapeutics Research, Gilead Sciences, Foster City, CA, 2022-present
- Executive Director, Discovery Biologics, Merck Research Laboratories, Boston, MA, 2017-2022
- Volwiler Research Fellow and Project Director (2015-2017), Associate Director II and Project Director (2014-2015), Global Biologics, AbbVie Bioresearch Center, Worcester, MA, 2014-2017
- Associate Director I (2011-2014), Sr. Group Leader (2008-2011), Sr. Scientist III (2006-2008), Sr. Scientist II (2002-2006), Global Biologics, AbbVie Bioresearch Center, Worcester, MA, 2002-2014
- Scientist II, Functional Genomics, Interleukin Genetics, Waltham, MA, 2002
- Instructor in Medicine, Vascular Biology Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 2001-2002
- Post-doc/Research Fellow, Cardiovascular Biology Laboratory, Harvard School of Public Health, and Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, 1998-2000
Education
- Doctor of Science, Division of Biological Sciences, Harvard School of Public Health, Boston, MA, 1992-1998
- PhD program in Cell Biology, New York University School of Medicine, New York, NY (Transferred to Harvard after the first year), 1991-1992
- Bachelor of Science, Zoology, National Taiwan University, Taipei, Taiwan, 1985-1989
Professional Societies
- Member, American Society for Biochemistry and Molecular Biology, 1996-Present
- Antibody Society, 2016-Present
Honors and Awards
- President’s Award, AbbVie Inc., 2014
- Donalee Tabern Outstanding Researcher, Volwiler Society, Abbott Laboratories, 2009
- National Research Service Award, National Institutes of Health, 2001
- Edgar Haber Award, Harvard School of Public Health, 1998
- Travel Award, Vascular Biology ’97, American Heart Association, 1997
- President’s Awards, National Taiwan University, 1989
- Dr. Hsieh Te-Kuei Medical Scholarship, National Taiwan University, 1988